Technology and Innovation Advancements
Seagate Technology (STX) reported strong fiscal Q2 2025 results with revenue increasing to $2.33 billion. The company achieved GAAP diluted EPS of $1.55 and non-GAAP diluted EPS of $2.03. Financial highlights include cash flow from operations of $221 million and free cash flow of $150 million. Seagate began ramping HAMR-based Mozaic products to its lead cloud customer with capacities up to 36 terabytes. View the detailed report.
Sinclair Broadcast Group (SBGI) and PBS Reno launched KNPB-VC, a new virtual ATSC 3.0 channel offering enhanced viewing features such as Advanced HDR by Technicolor. This marks Sinclair's third implementation of its agreement with America's Public Television Stations. Read more here.
Tuya Smart (TUYA) launched a smart door lock with Matter and Apple Wallet, attracting attention at CES 2025 for its advanced security features. Discover the details.
WiSA Technologies (WISA) reported a successful CES 2025, showcasing groundbreaking Web 3.0 technologies and receiving recognition from Forbes. More insights here.
Vuzix (VUZI) has signed a distribution agreement with Evantek Pte, a system integrator in Asia Pacific. This expands the reach of Vuzix M400 smart glasses in industries aiming to enhance productivity. Read more here.
Axalta Coating Systems (AXTA) launched the Axalta Fellows Forum, a network to innovate new technologies alongside their Technology Incubator team. Learn more.
ServiceNow (NOW) expanded its global partner program, intensifying efforts in AI solutions with new investments and specializations. Discover the benefits.
Pharmaceuticals and Healthcare
NeurAxis (NRXS) expanded its medical policy coverage for its IB-Stim technology with a major insurer, now covering over 5.1 million lives across 13 states. This expands coverage for children with abdominal pain-related disorders. Further details.
Catalyst Pharmaceuticals (CPRX) announced the launch of FIRDAPSE® in Japan by sub-licensee DyDo Pharma, broadening treatment access for Lambert-Eaton myasthenic syndrome. Discover more.
Johnson & Johnson (JNJ) received FDA approval for SPRAVATO®, marking it as the first standalone therapy for adults with treatment-resistant depression. Learn more.
Amylyx Pharmaceuticals (AMLX) announced the FDA lifted the clinical hold on its Phase 1 trial of AMX0114 for ALS, resuming screening and enrollment. More information.
Sanara MedTech (SMTI) has announced an exclusive license and distribution agreement with Biomimetic Innovations, alongside a minority investment of up to €8.0 million for approximately 12.5% equity stake in BMI. This agreement grants Sanara exclusive U.S. rights to market OsStic, a synthetic injectable structural bio-adhesive bone void filler. Read further details.
Inhibrx Biosciences (NASDAQ: INBX) has released preliminary data from its Phase 1 trial of ozekibart (INBRX-109) combined with FOLFIRI for treating advanced colorectal cancer. The trial showed promising results among 10 evaluated patients, including one complete response, three partial responses, and six stable disease cases. Based on these encouraging results, Inhibrx has initiated an expansion cohort to enroll up to 50 patients, with data expected in Q3 2025. Read more.
Adagene (NASDAQ: ADAG) will present updated clinical data from its Phase 1b/2 study of ADG126 in combination with KEYTRUDA® for colorectal cancer at the ASCO Gastrointestinal Cancers Symposium. The company highlighted the unmet need in treatment and the importance of targeting CTLA-4 for durable responses in cold tumors. Further details.
Financial Results and Reports
United Airlines (UAL) achieved record fourth quarter profits, reporting full-year pre-tax earnings of $4.2 billion with a 7.3% pre-tax margin, surpassing expectations. The airline saw notable gains in premium and corporate revenues. Full details here.
Capital One (COF) reported Q4 2024 net income of $1.1 billion, or $2.67 per share, with total net revenue increasing 2% to $10.2 billion. See the complete report.
Charles Schwab (SCHW) announced robust Q4 earnings with notable revenue growth, highlighting investor confidence amidst market challenges. See the details.
Worksport reported strong Q4 2024 unaudited results with significant revenue and margin growth, driven by shifts towards high-value products. View the full report.
Zions Bancorporation (ZION) reported Q4 2024 net earnings of $200 million, or $1.34 per diluted common share, a strong performance compared to $116 million the previous year. Explore the complete results.
Progress (PRGS) reported strong Q4 and full-year 2024 results, with Q4 revenue up 21% year-over-year to $215 million, and significant annual recurring revenue growth. View more details.
SmartFinancial (SMBK) reported strong Q4 2024 results with net income of $9.6 million, or $0.57 per diluted share. The company showed net interest margin expansion to 3.24% and significant deposit and loan growth. More here.
Pinnacle Financial Partners (PNFP) reported Q4 2024 diluted earnings per share of $1.91, marking a significant increase from the previous year. The company maintained robust balance sheet growth and strategically lowered average deposit costs in a challenging interest rate environment. Read further details.
Strategic Moves and Partnerships
Morgan Stanley Infrastructure Partners announced a strategic partnership with Torch Clean Energy, advancing solar and storage capabilities with expanded development operations. Read more.
Hyliion Holdings (HYLN) and ElectriGen secured a $6 million federal grant to advance methane emission reductions in the oil and gas sector with their KARNO™ generators. Discover more.
EVI Industries (EVI) announced its acquisition of Haiges Machinery, marking its first venture into the Midwest region and reinforcing its growth in the commercial laundry sector. Read more.
Pitney Bowes (PBI) acquired the presort business of Royal Alliances, bolstering its nationwide presort services across the U.S. More information.
Air Lease Corporation (AL) announced a $2.0 billion commercial paper program, allowing it to issue short-term, unsecured commercial paper notes for general corporate purposes, including aircraft purchases and debt repayment. Read the details.
Corporate Announcements
Cosmos Health (COSM) CEO Greg Siokas acquired 647,809 common shares worth $425,000, reflecting confidence in the company's future prospects. More details.
Scilex Holding Company (SCLX) extends the maturity date of a promissory note issued to Oramed Pharmaceuticals to December 31, 2025, positioning itself for strategic growth in pain management and neurodegenerative treatments. Read more.
Vroom (VRM) has provided an update regarding the trading status of its common stock and warrants following its emergence from Chapter 11 bankruptcy. The company is working towards relisting the stock on a national securities exchange. Learn more.
abrdn Emerging Markets Equity Income Fund (AEF) has announced a cash tender offer to buy up to 20% of its outstanding shares at 98% of NAV. This offer may influence share pricing and is scheduled to end on February 20, 2025. Read more on this.
